Figure 2.
Figure 2. Proliferation of CD4+ and CD8+ T lymphocytes in response to anti-CD3. (A) Proliferation of CD4+25+cells compared with CD4+25-and CD8+ cells. T cells (5 × 104/well) were incubated with 1 × 105 irradiated APCs and 1 μg/mL anti-CD3. Proliferation was measured by 3H-thymidine incorporation during the last 12 hours of a 72-hour culture. Results are the mean ± SD of triplicate wells. (B) Effect of CD4+25+ TREGs on the proliferation of CD8+ cells in response to anti-CD3. Two days after the intraperitoneal administration of 2 mg CY, CD4+25+ TREGs were separated from spleens of treated and control mice. CD8+ cells (5 × 104) from healthy mice were incubated with 1 × 105 irradiated APCs from healthy mice and 1 μg/mL anti-CD3 along with either no T, 5 × 104, 5 × 104 TREGs from untreated mice, or 5 × 104 TREGs from CY-treated mice. Proliferation was measured by 3H-thymidine incorporation during the last 12 hours of a 72-hour culture. Results are the mean ± SD of triplicate wells. Data are representative of 3 experiments. (C) Effect of CD4+25+ TREGs on the proliferation of CD4+25- cells in response to anti-CD3. Two days after the intraperitoneal administration of 2 mg CY, CD4+25+ TREGs were separated from spleens of treated and control mice. CD4+25- cells (5 × 104) from healthy mice were incubated with 1 × 105 irradiated APCs from healthy mice and 1 μg/mL anti-CD3 along with either no TREGs, 5 × 104 ,5 × 104 TREGs from untreated mice, or 5 × 104 TREGs from CY-treated mice. Proliferation was measured by 3H-thymidine incorporation during the last 12 hours of a 72-hour culture. Results are the mean ± SD of triplicate wells. Data are representative of 3 experiments. (D) Effect of CD4+25+ TREGs on the proliferation of CD8+ cells in response to anti-CD3. Ten days after the intraperitoneal administration of 2 mg CY, CD4+25+ TREGs were separated from spleens of treated and control mice. CD8+ cells (5 × 104) from healthy mice were incubated with 1 × 105 irradiated APCs from healthy mice and 1 μg/mL anti-CD3 along with either no TREGs 5 × 104 TREGs from untreated mice, or 5 × 104 TREGs from CY-treated mice. Proliferation was measured by 3H-thymidine incorporation during the last 12 hours of a 72-hour culture. Results are the mean ± SD of triplicate wells. Data are representative of 3 experiments. (E) Effect of CD4+25+ TREGs on the proliferation of CD4+25- cells in response to anti-CD3. Two days after the intraperitoneal administration of 2 mg CY, CD4+25+ TREGs were separated from spleens of treated and control mice. CD4+25- cells (5 × 104) from healthy mice were incubated with 1 × 105 irradiated APCs from healthy mice and 1 μg/mL anti-CD3 along with either no TREGs 5 × 104 TREGs from untreated mice, or 5 × 104 TREGs from CY-treated mice. Proliferation was measured by 3H-thymidine incorporation during the last 12 hours of a 72-hour culture. Results are the mean ± SD of triplicate wells. Data are representative of 3 experiments.

Proliferation of CD4+ and CD8+ T lymphocytes in response to anti-CD3. (A) Proliferation of CD4+25+cells compared with CD4+25-and CD8+ cells. T cells (5 × 104/well) were incubated with 1 × 105 irradiated APCs and 1 μg/mL anti-CD3. Proliferation was measured by 3H-thymidine incorporation during the last 12 hours of a 72-hour culture. Results are the mean ± SD of triplicate wells. (B) Effect of CD4+25+ TREGs on the proliferation of CD8+ cells in response to anti-CD3. Two days after the intraperitoneal administration of 2 mg CY, CD4+25+ TREGs were separated from spleens of treated and control mice. CD8+ cells (5 × 104) from healthy mice were incubated with 1 × 105 irradiated APCs from healthy mice and 1 μg/mL anti-CD3 along with either no T, 5 × 104, 5 × 104 TREGs from untreated mice, or 5 × 104 TREGs from CY-treated mice. Proliferation was measured by 3H-thymidine incorporation during the last 12 hours of a 72-hour culture. Results are the mean ± SD of triplicate wells. Data are representative of 3 experiments. (C) Effect of CD4+25+ TREGs on the proliferation of CD4+25- cells in response to anti-CD3. Two days after the intraperitoneal administration of 2 mg CY, CD4+25+ TREGs were separated from spleens of treated and control mice. CD4+25- cells (5 × 104) from healthy mice were incubated with 1 × 105 irradiated APCs from healthy mice and 1 μg/mL anti-CD3 along with either no TREGs, 5 × 104 ,5 × 104 TREGs from untreated mice, or 5 × 104 TREGs from CY-treated mice. Proliferation was measured by 3H-thymidine incorporation during the last 12 hours of a 72-hour culture. Results are the mean ± SD of triplicate wells. Data are representative of 3 experiments. (D) Effect of CD4+25+ TREGs on the proliferation of CD8+ cells in response to anti-CD3. Ten days after the intraperitoneal administration of 2 mg CY, CD4+25+ TREGs were separated from spleens of treated and control mice. CD8+ cells (5 × 104) from healthy mice were incubated with 1 × 105 irradiated APCs from healthy mice and 1 μg/mL anti-CD3 along with either no TREGs 5 × 104 TREGs from untreated mice, or 5 × 104 TREGs from CY-treated mice. Proliferation was measured by 3H-thymidine incorporation during the last 12 hours of a 72-hour culture. Results are the mean ± SD of triplicate wells. Data are representative of 3 experiments. (E) Effect of CD4+25+ TREGs on the proliferation of CD4+25- cells in response to anti-CD3. Two days after the intraperitoneal administration of 2 mg CY, CD4+25+ TREGs were separated from spleens of treated and control mice. CD4+25- cells (5 × 104) from healthy mice were incubated with 1 × 105 irradiated APCs from healthy mice and 1 μg/mL anti-CD3 along with either no TREGs 5 × 104 TREGs from untreated mice, or 5 × 104 TREGs from CY-treated mice. Proliferation was measured by 3H-thymidine incorporation during the last 12 hours of a 72-hour culture. Results are the mean ± SD of triplicate wells. Data are representative of 3 experiments.

Close Modal

or Create an Account

Close Modal
Close Modal